{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-02T12:20:27.765517+00:00",
  "news": [
    {
      "title": "A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5\" target=\"_blank\">A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-02T05:11:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "How Amgen’s (AMGN) Dividend and Tezspire Approval Could Shape Investor Expectations for 2025 - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxORlBiS2FSS2RnNEdVa1drYlZNSnFqLXlkM05EX25sdkJBUW1Lei15Ti0wTlZ2WjVPSzVrOVdBcGNnMUh3Vm5rU2J0d1FlX1NHS01lT0hWTzFOVnduOFh0WWF2QkFpZjZvOGt0Vlg5N0NOQ0ZTUERwMDEzZ2V2OUl4RURFSlpwYmVPcS1ZUFplbWlSZU9ERHl5WnRzVk1ELUEyaEZHLTlITVJKcjNVZTNuQjRyd2FuZTA3VmwtbnU1YURGdVFJZUh5d3BHRTM0SGFIZ3JTMUZR0gHbAUFVX3lxTE16aE01V0hsZWtyN3BXTWYzanhtbGJCWlNrN1NwTnU2WmUxX3hLc3poWUN3LUszYjFTVlpNSWc0cmNEcEdVUWxrT3BHOUZlRkZaUGNZN250UG1IVHpQYUdmZ2Y4M2t2RTZKM3BPRlN4czllSEZpck1ROE1zWWl0endZeWdMWm5CRm5IbURRbFZFMzN0d2NwcjJtbkp5MjdMazBsXzZCWHo1TWtyd0dMRDNPRHhDLXhvQThSeTBBUzBaM2MyU1loVkp0SmVIXzFpZXZFdU5ORVV0R2U0UQ?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">How Amgen’s (AMGN) Dividend and Tezspire Approval Could Shape Investor Expectations for 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-02T01:57:03+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPUnp3MkxtYlMtczUtNXVTMWQ2eExoeUgtX2NuUWU5eFB3bDhKRTY3WTBXelpSVmlIY2x0SzB6NzJqcVdoa184dmQwVzk4Q0FZWWMtbUVaUHUyVERldFR5dU90ZjF3TElmSVFMeTR2ZDF1RFV4ZEE1REdKd2lVOEdTV2ZtZjUyRHZMQzR1VkRpbWkzWGttQUdBQjNrWlJ3cXZsY1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxPUnp3MkxtYlMtczUtNXVTMWQ2eExoeUgtX2NuUWU5eFB3bDhKRTY3WTBXelpSVmlIY2x0SzB6NzJqcVdoa184dmQwVzk4Q0FZWWMtbUVaUHUyVERldFR5dU90ZjF3TElmSVFMeTR2ZDF1RFV4ZEE1REdKd2lVOEdTV2ZtZjUyRHZMQzR1VkRpbWkzWGttQUdBQjNrWlJ3cXZsY1E?oc=5\" target=\"_blank\">AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-10-31T20:01:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen (AMGN) Maintains Quarterly Dividend of $2.38 Per Share - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQdXI4OHBpODRyMFk5bVF6NkxmaThRaGs0ZnVVSlJUR2ZocXdic2JaWHZ4R0NJMWRHWU1CbHUwVm41V3U1MGtzdlhoRGhuOU4wY1RkYjZKdkZxYXE0M0NiNlNEWW82Ty1UY1psbW9TZV9uU0p6bndISzlYWFVWOE5nS215WlhzcDR1b3AxSjlJWjBaMkxzemdqaFE3WQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxQdXI4OHBpODRyMFk5bVF6NkxmaThRaGs0ZnVVSlJUR2ZocXdic2JaWHZ4R0NJMWRHWU1CbHUwVm41V3U1MGtzdlhoRGhuOU4wY1RkYjZKdkZxYXE0M0NiNlNEWW82Ty1UY1psbW9TZV9uU0p6bndISzlYWFVWOE5nS215WlhzcDR1b3AxSjlJWjBaMkxzemdqaFE3WQ?oc=5\" target=\"_blank\">Amgen (AMGN) Maintains Quarterly Dividend of $2.38 Per Share</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2025-11-02T11:01:10+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "Syverson Strege & Co Makes New Investment in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPOV9HYnhkWjI1dXlLdG5IbUd1T1hWZnhjYTZLNWtycTVnc2hvOHlKYmVBZFFnNWFwbXRac19JUHN5aGY1WFh1SjNNM2ptdUxxSFIxaTE2aVFMTTJwbXR5dXFfaUJ0NUVUMk9oXzJhckd2UG4tQmVqUDEtRGsxNmxzMDdzYjJ6YTBWVjZIb1BmWUYwMVF4eHJEN1k2QTI3TU92UTA1bUM0TktQZ18ycVIxV1FHektaZndMUFE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiugFBVV95cUxPOV9HYnhkWjI1dXlLdG5IbUd1T1hWZnhjYTZLNWtycTVnc2hvOHlKYmVBZFFnNWFwbXRac19JUHN5aGY1WFh1SjNNM2ptdUxxSFIxaTE2aVFMTTJwbXR5dXFfaUJ0NUVUMk9oXzJhckd2UG4tQmVqUDEtRGsxNmxzMDdzYjJ6YTBWVjZIb1BmWUYwMVF4eHJEN1k2QTI3TU92UTA1bUM0TktQZ18ycVIxV1FHektaZndMUFE?oc=5\" target=\"_blank\">Syverson Strege & Co Makes New Investment in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-11-02T11:13:44+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen breaks ground on $600M research and development center in Thousand Oaks - Ventura County Star",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQV3FDUUEyLVNmSDhWYUE0aWZZb3hyZXBnMHZ6cUFYcU01T3Mzb19mTWhnUVJibGJuSVZRME9LSUlGMndNXzFTV3E5VFNWZG9qaXU1eFBxRmxBM1R6WmRKMUhjd21jM21Hd21SUWxzaVkyOEZscGFmN2ozd3RCcDNjTlEtVjRENFgwbFgxUU9KRVkzUG5sNzNwbVBRWGktZ0YxMURZUEV4WUJHS2xrTXpWY1JHX29Kcm1HUjlYa0JmNS0tcTZEVWY0ZjE2bVdSdDFYODI2am5fOHRoUUlORnpTRkVBQ0Q?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQV3FDUUEyLVNmSDhWYUE0aWZZb3hyZXBnMHZ6cUFYcU01T3Mzb19mTWhnUVJibGJuSVZRME9LSUlGMndNXzFTV3E5VFNWZG9qaXU1eFBxRmxBM1R6WmRKMUhjd21jM21Hd21SUWxzaVkyOEZscGFmN2ozd3RCcDNjTlEtVjRENFgwbFgxUU9KRVkzUG5sNzNwbVBRWGktZ0YxMURZUEV4WUJHS2xrTXpWY1JHX29Kcm1HUjlYa0JmNS0tcTZEVWY0ZjE2bVdSdDFYODI2am5fOHRoUUlORnpTRkVBQ0Q?oc=5\" target=\"_blank\">Amgen breaks ground on $600M research and development center in Thousand Oaks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Ventura County Star</font>",
      "published": "2025-10-31T16:53:58+00:00",
      "source": "Ventura County Star"
    },
    {
      "title": "Amgen Again Challenges Colo. Price Cap For Arthritis Drug - Law360",
      "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPWXQ0aE5PNG52clNQTVVOTEtOYU1BRlVwem00NTF4VE5Sa1F5VEVqa2xtbGpTeXdfZUo0NkZyOGRNQkF4TUpON1V3SmhWNDg5MU9LWG1CeGtiTU1nZlJnTUdvSm1RTDh6bGU4SjQ0N1JiRHNJMTRqdll4QnhYc0o0QUtZaGMxbWVmY2MyczQxV1k1SlJxWUJGdG5yaHXSAVZBVV95cUxQNVNMWGNrTFhkeThBQ1dYVFVyaUtKN1BCQ3UzYmNYUXFDSnlDTUo1VE5rTkcyRjlCa0hqbEh4U2FHMmkzbFlUbTRTc0k3Z1lIbW11TXczdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxPWXQ0aE5PNG52clNQTVVOTEtOYU1BRlVwem00NTF4VE5Sa1F5VEVqa2xtbGpTeXdfZUo0NkZyOGRNQkF4TUpON1V3SmhWNDg5MU9LWG1CeGtiTU1nZlJnTUdvSm1RTDh6bGU4SjQ0N1JiRHNJMTRqdll4QnhYc0o0QUtZaGMxbWVmY2MyczQxV1k1SlJxWUJGdG5yaHXSAVZBVV95cUxQNVNMWGNrTFhkeThBQ1dYVFVyaUtKN1BCQ3UzYmNYUXFDSnlDTUo1VE5rTkcyRjlCa0hqbEh4U2FHMmkzbFlUbTRTc0k3Z1lIbW11TXczdw?oc=5\" target=\"_blank\">Amgen Again Challenges Colo. Price Cap For Arthritis Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Law360</font>",
      "published": "2025-11-01T02:37:00+00:00",
      "source": "Law360"
    },
    {
      "title": "US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5\" target=\"_blank\">US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-17T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients - MyChesCo",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5\" target=\"_blank\">Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MyChesCo</font>",
      "published": "2025-10-27T04:00:00+00:00",
      "source": "MyChesCo"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S. - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5\" target=\"_blank\">$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-31",
      "close": 298.42999267578125
    },
    "history": [
      {
        "date": "2025-10-23",
        "close": 292.8900146484375
      },
      {
        "date": "2025-10-24",
        "close": 291.760009765625
      },
      {
        "date": "2025-10-27",
        "close": 291.1600036621094
      },
      {
        "date": "2025-10-28",
        "close": 292.0899963378906
      },
      {
        "date": "2025-10-29",
        "close": 291.7699890136719
      },
      {
        "date": "2025-10-30",
        "close": 292.0
      },
      {
        "date": "2025-10-31",
        "close": 298.42999267578125
      }
    ],
    "name": "Amgen Inc."
  }
}